Research graph
References from Accelerating therapeutic protein design with computational approaches toward the clinical stage. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/nrd.2017.227
10.1038/nrd.2017.227 · External reference
10.1016/j.tibs.2019.12.008
10.1016/j.tibs.2019.12.008 · External reference
Inverse pharmacology: Approaches and tools for introducing druggability into engineered proteins
10.1016/j.biotechadv.2019.107439 · 2019 · External reference
An overview of FDA-approved biologics medicines
10.1016/j.drudis.2014.09.003 · 2015 · External reference
10.1533/9781908818102
10.1533/9781908818102 · 2012 · External reference
Unresolved reference
External reference
10.1038/s41573-022-00501-8
10.1038/s41573-022-00501-8 · External reference
10.1038/s41570-022-00438-x
10.1038/s41570-022-00438-x · External reference
10.1038/nrd1695
10.1038/nrd1695 · External reference
Biophysical properties of the clinical-stage antibody landscape
10.1073/pnas.1616408114 · 2017 · External reference
10.1016/j.bej.2018.06.003
10.1016/j.bej.2018.06.003 · External reference
Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space, Nature
2022 · External reference
Machine learning prediction of antibody aggregation and viscosity for high concentration formulation development of protein therapeutics
10.1080/19420862.2022.2026208 · 2022 · External reference
10.1126/sciadv.abb0372
10.1126/sciadv.abb0372 · External reference
Derivatization with fatty acids in peptide and protein drug discovery
2022 · External reference
Function2Form Bridge—Toward synthetic protein holistic performance prediction, Proteins: Structure
10.1002/prot.25825 · 2020 · External reference
Determining druggability
10.1038/nrd2275 · 2007 · External reference
10.1016/b978-0-12-409547-2.12342-x
10.1016/b978-0-12-409547-2.12342-x · 2017 · External reference
Predicting Antibody Developability Profiles Through Early Stage Discovery Screening
10.1080/19420862.2020.1743053 · 2020 · External reference
10.1016/j.jconrel.2020.08.013
10.1016/j.jconrel.2020.08.013 · External reference
Gromiha, An in-silico method for identifying aggregation rate enhancer and mitigator mutations in proteins
10.1016/j.ijbiomac.2018.06.102 · 2018 · External reference
Unresolved reference
2020 · External reference
10.1016/s1359-6446(05)03624-x
10.1016/s1359-6446(05)03624-x · External reference
BDDCS, the Rule of 5 and drugability
10.1016/j.addr.2016.05.007 · 2016 · External reference
10.1023/a:1016212804288
10.1023/a:1016212804288 · External reference
10.1016/j.tips.2020.12.004
10.1016/j.tips.2020.12.004 · External reference
10.1016/j.sbi.2022.102343
10.1016/j.sbi.2022.102343 · External reference
Computational approaches to therapeutic antibody design: established methods and emerging trends
10.1093/bib/bbz095 · 2020 · External reference
Intrinsic physicochemical profile of marketed antibody-based biotherapeutics
10.1073/pnas.2020577118 · 2021 · External reference
10.1016/j.jconrel.2021.08.030
10.1016/j.jconrel.2021.08.030 · External reference
10.1038/s41570-018-0148
10.1038/s41570-018-0148 · External reference
Unresolved reference
2011 · External reference
10.1038/s41584-022-00877-2
10.1038/s41584-022-00877-2 · External reference
10.1002/anie.201403924
10.1002/anie.201403924 · External reference
10.1038/s41596-021-00597-z
10.1038/s41596-021-00597-z · External reference
10.1038/s41573-019-0050-3
10.1038/s41573-019-0050-3 · External reference
10.1038/nbt.4233
10.1038/nbt.4233 · External reference
10.1039/d0ra04028b
10.1039/d0ra04028b · External reference
10.1039/d0tb00061b
10.1039/d0tb00061b · External reference
Aggrescan3D (A3D) 2.0: prediction and engineering of protein solubility
10.1093/nar/gkz321 · 2019 · External reference
10.1126/science.add2187
10.1126/science.add2187 · External reference
Towards a Digital Bioprocess Replica: Computational Approaches in Biopharmaceutical Development and Manufacturing
10.1016/j.tibtech.2020.05.008 · 2020 · External reference
Developing a computational framework to advance bioprocess scale-up
10.1016/j.tibtech.2020.01.009 · 2020 · External reference
Unresolved reference
2021 · External reference
10.1080/17425247.2020.1813713
10.1080/17425247.2020.1813713 · External reference
10.1016/j.addr.2018.07.011
10.1016/j.addr.2018.07.011 · External reference
10.1016/j.jconrel.2013.05.041
10.1016/j.jconrel.2013.05.041 · External reference
Controlled loading of albumin-drug conjugates ex vivo for enhanced drug delivery and antitumor efficacy
10.1016/j.jconrel.2020.08.015 · 2020 · External reference
10.1038/s41571-021-00484-2
10.1038/s41571-021-00484-2 · External reference
10.1038/s41571-021-00470-8
10.1038/s41571-021-00470-8 · External reference
10.1002/smll.200801602
10.1002/smll.200801602 · External reference
Unresolved reference
2022 · External reference
10.1038/s41578-021-00358-0
10.1038/s41578-021-00358-0 · External reference
Harnessing protein corona for biomimetic nanomedicine design
2022 · External reference
10.1038/s41577-019-0269-6
10.1038/s41577-019-0269-6 · External reference
10.1038/s41573-020-0090-8
10.1038/s41573-020-0090-8 · External reference
10.1016/j.apsb.2021.05.004
10.1016/j.apsb.2021.05.004 · External reference
10.1016/j.drudis.2022.02.015
10.1016/j.drudis.2022.02.015 · External reference
10.1038/nrd2445
10.1038/nrd2445 · External reference
10.1038/s41551-021-00698-w
10.1038/s41551-021-00698-w · External reference
10.1038/s41589-022-01040-4
10.1038/s41589-022-01040-4 · External reference
10.1038/s41573-022-00521-4
10.1038/s41573-022-00521-4 · External reference
10.1038/s41573-022-00538-9
10.1038/s41573-022-00538-9 · External reference
10.1038/s41573-019-0053-0
10.1038/s41573-019-0053-0 · External reference
Shifting paradigms: biopharmaceuticals versus low molecular weight drugs
10.1016/s0378-5173(03)00376-4 · 2003 · External reference
10.1038/nrd.2018.183
10.1038/nrd.2018.183 · External reference
10.1016/j.csbj.2019.09.004 · Admitted local publication
Spray freeze drying: Emerging applications in drug delivery
10.1016/j.jconrel.2019.02.044 · 2019 · External reference
Advances in liquid formulations of parenteral therapeutic proteins
10.1016/j.biotechadv.2019.06.011 · 2019 · External reference
10.1016/j.jconrel.2018.08.001
10.1016/j.jconrel.2018.08.001 · External reference
10.1016/j.ejpb.2017.06.029
10.1016/j.ejpb.2017.06.029 · External reference
10.1016/j.addr.2016.11.004
10.1016/j.addr.2016.11.004 · External reference
10.1016/j.preteyeres.2020.100862
10.1016/j.preteyeres.2020.100862 · External reference
Impact of electroviscous effect on viscosity in developing highly concentrated protein formulations: Lessons from non-protein charged colloids
2019 · External reference
10.1038/s42256-022-00553-w
10.1038/s42256-022-00553-w · External reference
The RESP AI model accelerates the identification of tight-binding antibodies
10.1038/s41467-023-36028-8 · 2023 · External reference
Unresolved reference
2019 · External reference
10.1371/journal.pcbi.1009284
10.1371/journal.pcbi.1009284 · External reference
A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies, Nature
2021 · External reference
10.1038/s41592-021-01100-y
10.1038/s41592-021-01100-y · External reference
10.1038/s43588-021-00168-y
10.1038/s43588-021-00168-y · External reference
Antibody complementarity determining region design using high-capacity machine learning
10.1093/bioinformatics/btz895 · 2019 · External reference
DLAB: deep learning methods for structure-based virtual screening of antibodies
10.1093/bioinformatics/btab660 · 2021 · External reference
ProAffiMuSeq: sequence-based method to predict the binding free energy change of protein–protein complexes upon mutation using functional classification
10.1093/bioinformatics/btz829 · 2019 · External reference
DeepRank: a deep learning framework for data mining 3D protein-protein interfaces
10.1038/s41467-021-27396-0 · 2021 · External reference
10.1093/nar/gkz383
10.1093/nar/gkz383 · External reference
mCSM-AB2: guiding rational antibody design using graph-based signatures
10.1093/bioinformatics/btz779 · 2019 · External reference
mmCSM-AB: guiding rational antibody engineering through multiple point mutations
10.1093/nar/gkaa389 · 2020 · External reference
mmCSM-PPI: predicting the effects of multiple point mutations on protein–protein interactions
10.1093/nar/gkab273 · 2021 · External reference
A topology-based network tree for the prediction of protein–protein binding affinity changes following mutation
10.1038/s42256-020-0149-6 · 2020 · External reference
10.1016/j.isci.2021.102979
10.1016/j.isci.2021.102979 · External reference
MutaBind2: Predicting the Impacts of Single and Multiple Mutations on Protein-Protein Interactions
10.1016/j.isci.2020.100939 · 2020 · External reference
SSIPe: accurately estimating protein–protein binding affinity change upon mutations using evolutionary profiles in combination with an optimized physical energy function
10.1093/bioinformatics/btz926 · 2019 · External reference
Cost function network-based design of protein–protein interactions: predicting changes in binding affinity
10.1093/bioinformatics/bty092 · 2018 · External reference
PPI-Affinity: A Web Tool for the Prediction and Optimization of Protein–Peptide and Protein–Protein Binding Affinity
10.1021/acs.jproteome.2c00020 · 2022 · External reference
TopologyNet: Topology based deep convolutional and multi-task neural networks for biomolecular property predictions
2017 · External reference
In silico proof of principle of machine learning-based antibody design at unconstrained scale
10.1080/19420862.2022.2031482 · 2022 · External reference
Predicting antibody binders and generating synthetic antibodies using deep learning
10.1080/19420862.2022.2069075 · 2022 · External reference
10.1371/journal.pcbi.1006980
10.1371/journal.pcbi.1006980 · External reference
Computational counterselection identifies nonspecific therapeutic biologic candidates, Cell Reports
2022 · External reference
10.7554/elife.61393
10.7554/elife.61393 · External reference
10.1038/s41551-021-00699-9
10.1038/s41551-021-00699-9 · External reference
An in silico method to assess antibody fragment polyreactivity
10.1038/s41467-022-35276-4 · 2022 · External reference
10.1038/s41592-019-0598-1
10.1038/s41592-019-0598-1 · External reference
Sampling of structure and sequence space of small protein folds
10.1038/s41467-022-34937-8 · 2022 · External reference
Unresolved reference
2022 · External reference
DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability
10.1093/nar/gky300 · 2018 · External reference
10.1002/pro.3942
10.1002/pro.3942 · External reference
DeepDDG: Predicting the Stability Change of Protein Point Mutations Using Neural Networks
10.1021/acs.jcim.8b00697 · 2019 · External reference
Clustered tree regression to learn protein energy change with mutated amino acid
2022 · External reference
PROST: AlphaFold2-aware Sequence-Based Predictor to Estimate Protein Stability Changes upon Missense Mutations
10.1021/acs.jcim.2c00799 · 2022 · External reference
PremPS: Predicting the impact of missense mutations on protein stability
2020 · External reference
10.1016/j.csbj.2020.02.021
10.1016/j.csbj.2020.02.021 · External reference
PON-tstab: Protein Variant Stability Predictor
2018 · External reference
Unresolved reference
2022 · External reference
10.1021/acs.jcim.1c00201
10.1021/acs.jcim.1c00201 · External reference
SCONES: self-consistent neural network for protein stability prediction upon mutation
10.1021/acs.jpcb.1c04913 · 2021 · External reference
pStab: prediction of stable mutants, unfolding curves, stability maps and protein electrostatic frustration
10.1093/bioinformatics/btx697 · 2017 · External reference
10.1021/acs.jcim.0c01470
10.1021/acs.jcim.0c01470 · External reference
10.1016/j.jmb.2021.167375
10.1016/j.jmb.2021.167375 · External reference
10.1021/acs.molpharmaceut.2c00453
10.1021/acs.molpharmaceut.2c00453 · External reference
Iii, Deciphering protein evolution and fitness landscapes with latent space models
10.1038/s41467-019-13633-0 · 2019 · External reference
Enhancing thermostability of a psychrophilic alpha-amylase by the structural energy optimization in the trajectories of molecular dynamics simulations
10.1016/j.ijbiomac.2019.10.004 · 2020 · External reference
Aggregation time machine: a platform for the prediction and optimization of long-term antibody stability using short-term kinetic analysis
10.1021/acs.jmedchem.1c02010 · 2022 · External reference
A computational method for predicting the aggregation propensity of IgG1 and IgG4(P) mAbs in common storage buffers
10.1080/19420862.2022.2138092 · 2022 · External reference
ANuPP: A Versatile Tool to Predict Aggregation Nucleating Regions in Peptides and Proteins
10.1016/j.jmb.2020.11.006 · 2021 · External reference
10.1016/j.amc.2019.04.015
10.1016/j.amc.2019.04.015 · External reference
10.1038/s41467-020-17207-3
10.1038/s41467-020-17207-3 · External reference
Accurate prediction of protein beta-aggregation with generalized statistical potentials
10.1093/bioinformatics/btz912 · 2019 · External reference
10.1021/acs.molpharmaceut.8b00115
10.1021/acs.molpharmaceut.8b00115 · External reference
10.1016/j.isci.2022.105173
10.1016/j.isci.2022.105173 · External reference
10.1080/17460441.2019.1637413
10.1080/17460441.2019.1637413 · External reference
ProGAN: Protein solubility generative adversarial nets for data augmentation in DNN framework
10.1016/j.compchemeng.2019.106533 · 2019 · External reference
10.1371/journal.pcbi.1007722
10.1371/journal.pcbi.1007722 · External reference
PaRSnIP: sequence-based protein solubility prediction using gradient boosting machine
10.1093/bioinformatics/btx662 · 2017 · External reference
DeepSol: a deep learning framework for sequence-based protein solubility prediction
10.1093/bioinformatics/bty166 · 2018 · External reference
SOLart: a structure-based method to predict protein solubility and aggregation
10.1093/bioinformatics/btz773 · 2019 · External reference
10.3390/ijms22158027
10.3390/ijms22158027 · External reference
SoluProt: prediction of soluble protein expression in Escherichia coli
10.1093/bioinformatics/btaa1102 · 2021 · External reference
Tosatto, SODA: prediction of protein solubility from disorder and aggregation propensity
10.1093/nar/gkx412 · 2017 · External reference
Development of QSAR models for in silico screening of antibody solubility
10.1080/19420862.2022.2062807 · 2022 · External reference
Develop machine learning-based regression predictive models for engineering protein solubility
10.1093/bioinformatics/btz294 · 2019 · External reference
10.1371/journal.pcbi.1008736
10.1371/journal.pcbi.1008736 · External reference
10.1016/j.csbj.2022.04.035
10.1016/j.csbj.2022.04.035 · External reference
Modeling and mitigation of high-concentration antibody viscosity through structure-based computer-aided protein design
10.1371/journal.pone.0232713 · 2020 · External reference
10.1021/acs.molpharmaceut.0c01073
10.1021/acs.molpharmaceut.0c01073 · External reference
Unresolved reference
2020 · External reference
Calculation of therapeutic antibody viscosity with coarse-grained models, hydrodynamic calculations and machine learning-based parameters
10.1080/19420862.2021.1907882 · 2021 · External reference
10.1080/19420862.2017.1285479
10.1080/19420862.2017.1285479 · External reference
Multiscale Coarse-Grained Approach to Investigate Self-Association of Antibodies
10.1016/j.bpj.2020.04.022 · 2020 · External reference
BioPhi: A platform for antibody design, humanization, and humanness evaluation based on natural antibody repertoires and deep learning
10.1080/19420862.2021.2020203 · 2022 · External reference
10.1016/j.str.2021.11.006
10.1016/j.str.2021.11.006 · External reference
10.1093/nar/gkx346
10.1093/nar/gkx346 · External reference
10.1093/bioinformatics/btab434
10.1093/bioinformatics/btab434 · External reference
Unresolved reference
2018 · External reference
LBCEPred: a machine learning model to predict linear B-cell epitopes
10.1093/bib/bbac035 · 2022 · External reference
10.1007/978-1-4939-6637-0_20
10.1007/978-1-4939-6637-0_20 · 2017 · External reference
10.1021/acs.jcim.1c00056
10.1021/acs.jcim.1c00056 · External reference
10.1093/nar/gkaa379
10.1093/nar/gkaa379 · External reference
10.1371/journal.pcbi.1005983
10.1371/journal.pcbi.1005983 · External reference
Unresolved reference
2019 · External reference
10.1016/j.procbio.2020.01.022
10.1016/j.procbio.2020.01.022 · External reference
Directed evolution of and structural insights into antibody-mediated disruption of a stable receptor-ligand complex
10.1038/s41467-021-27397-z · 2021 · External reference
10.1186/s12929-019-0592-z
10.1186/s12929-019-0592-z · External reference
10.1016/j.tibtech.2021.03.003
10.1016/j.tibtech.2021.03.003 · External reference
10.1038/nbt1126
10.1038/nbt1126 · External reference
10.1038/82407
10.1038/82407 · External reference
10.1039/c8cs00981c
10.1039/c8cs00981c · External reference
Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging
10.1073/pnas.1519623112 · 2015 · External reference
10.1016/j.cell.2022.08.024
10.1016/j.cell.2022.08.024 · External reference
10.1016/j.celrep.2018.10.081
10.1016/j.celrep.2018.10.081 · External reference
10.1038/s41592-019-0496-6
10.1038/s41592-019-0496-6 · External reference
10.1073/pnas.1901979116
10.1073/pnas.1901979116 · External reference
10.1038/nature19946
10.1038/nature19946 · External reference
10.1016/j.tibtech.2020.10.003
10.1016/j.tibtech.2020.10.003 · External reference
10.1016/j.sbi.2022.102379
10.1016/j.sbi.2022.102379 · External reference
10.1038/s41557-021-00766-3
10.1038/s41557-021-00766-3 · External reference
10.1016/j.cbpa.2021.08.004
10.1016/j.cbpa.2021.08.004 · External reference
10.1016/j.jbc.2021.100558
10.1016/j.jbc.2021.100558 · External reference
History of De Novo Protein Design: Minimal, Rational, and Computational
10.1016/j.jmb.2021.167160 · 2021 · External reference
Controllable protein design with language models
10.1038/s42256-022-00499-z · 2022 · External reference
10.1038/s41592-020-0848-2
10.1038/s41592-020-0848-2 · External reference
Protein design via deep learning
10.1093/bib/bbac102 · 2022 · External reference
10.1016/j.sbi.2021.03.009
10.1016/j.sbi.2021.03.009 · External reference
On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles
10.1073/pnas.2109256118 · 2021 · External reference
10.1073/pnas.1919755117
10.1073/pnas.1919755117 · External reference
10.1021/acsnano.9b02774
10.1021/acsnano.9b02774 · External reference
Norepinephrine transporter-derived homing peptides enable rapid endocytosis of drug delivery nanovehicles into neuroblastoma cells
10.1186/s12951-020-00654-x · 2020 · External reference
10.1016/j.molliq.2021.115949
10.1016/j.molliq.2021.115949 · External reference
10.1016/j.copbio.2019.01.008
10.1016/j.copbio.2019.01.008 · External reference
Science and art of protein formulation development
10.1016/j.ijpharm.2019.118505 · 2019 · External reference
Critical considerations in the formulation development of parenteral biologic drugs
10.1016/j.drudis.2019.12.011 · 2020 · External reference
Chemical and physical instabilities in manufacturing and storage of therapeutic proteins
10.1016/j.copbio.2019.01.014 · 2019 · External reference
Predicting the stability of mutant proteins by computational approaches: an overview
10.1093/bib/bbaa074 · 2021 · External reference
10.1016/j.sbi.2015.09.002
10.1016/j.sbi.2015.09.002 · External reference
10.1038/nature02261
10.1038/nature02261 · External reference
10.1146/annurev-biochem-062917-012102
10.1146/annurev-biochem-062917-012102 · External reference
10.1016/j.cis.2019.102078
10.1016/j.cis.2019.102078 · External reference
Ion redistribution in an electric double layer
10.1016/s0021-9797(02)00229-1 · 2003 · External reference
Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering
10.1021/acs.molpharmaceut.9b00687 · 2019 · External reference
BayeStab: Predicting effects of mutations on protein stability with uncertainty quantification
10.1002/pro.4467 · 2022 · External reference
10.1073/pnas.1903888116
10.1073/pnas.1903888116 · External reference
Clustered tree regression to learn protein energy change with mutated amino acid
2022 · External reference
10.1038/nmat4822
10.1038/nmat4822 · External reference
10.1021/acsnano.2c12440
10.1021/acsnano.2c12440 · External reference
High-density lipoprotein-mimicking nanodiscs for chemo-immunotherapy against glioblastoma multiforme
2019 · External reference
Advancing the pharmaceutical potential of bioinorganic hybrid lipid-based assemblies
10.1002/advs.201800564 · 2018 · External reference
Melittin Tryptophan Substitution with a Fluorescent Amino Acid Reveals the Structural Basis of Selective Antitumor Effect and Subcellular Localization in Tumor Cells
10.3390/toxins14070428 · 2022 · External reference
10.1021/acs.langmuir.2c03082
10.1021/acs.langmuir.2c03082 · External reference
10.1038/s41551-019-0470-8
10.1038/s41551-019-0470-8 · External reference
Commentary: New perspectives on protein aggregation during Biopharmaceutical development
10.1016/j.ijpharm.2018.09.049 · 2018 · External reference
10.1016/j.sbi.2020.01.005
10.1016/j.sbi.2020.01.005 · External reference
Driving Forces for Nonnative Protein Aggregation and Approaches to Predict Aggregation-Prone Regions
10.1146/annurev-chembioeng-060816-101404 · 2017 · External reference
10.1016/j.tibtech.2014.05.005
10.1016/j.tibtech.2014.05.005 · External reference
10.1016/j.csbj.2020.05.026
10.1016/j.csbj.2020.05.026 · External reference
10.1007/s12551-021-00778-w
10.1007/s12551-021-00778-w · External reference
10.1073/pnas.0904191106
10.1073/pnas.0904191106 · External reference
AggScore: Prediction of aggregation-prone regions in proteins based on the distribution of surface patches
10.1002/prot.25594 · 2018 · External reference
Evaluation of in silico tools for the prediction of protein and peptide aggregation on diverse datasets
10.1093/bib/bbab240 · 2021 · External reference
10.1021/jacs.2c09232
10.1021/jacs.2c09232 · External reference
Stabilizers and their interaction with formulation components in frozen and freeze-dried protein formulations
10.1016/j.addr.2021.03.003 · 2021 · External reference
10.1016/j.addr.2011.06.011
10.1016/j.addr.2011.06.011 · External reference
Machine Learning on a Robotic Platform for the Design of Polymer–Protein Hybrids
10.1002/adma.202201809 · 2022 · External reference
Computational Characterization of Antibody–Excipient Interactions for Rational Excipient Selection Using the Site Identification by Ligand Competitive Saturation-Biologics Approach
10.1021/acs.molpharmaceut.0c00775 · 2020 · External reference
Bioinformatics approaches for improved recombinant protein production in Escherichia coli: protein solubility prediction
10.1093/bib/bbt057 · 2014 · External reference
Recombinant protein solubility—does more mean better?
10.1038/nbt0707-718 · 2007 · External reference
Genetic screens and directed evolution for protein solubility
10.1016/s1367-5931(02)00017-0 · 2003 · External reference
In vivo and in vitro protein solubility assays using split GFP
10.1038/nmeth932 · 2006 · External reference
10.1038/nprot.2007.400
10.1038/nprot.2007.400 · External reference
Development of a high-throughput solubility screening assay for use in antibody discovery
10.1080/19420862.2019.1589851 · 2019 · External reference
Trade-offs between enzyme fitness and solubility illuminated by deep mutational scanning
10.1073/pnas.1614437114 · 2017 · External reference
Viscosity of concentrated therapeutic protein compositions
10.1016/j.addr.2011.09.008 · 2011 · External reference
10.1016/j.ijpharm.2018.11.012
10.1016/j.ijpharm.2018.11.012 · External reference
10.1016/j.addr.2006.03.011
10.1016/j.addr.2006.03.011 · External reference
10.1038/nrd4363
10.1038/nrd4363 · External reference
10.1016/j.copbio.2009.10.006
10.1016/j.copbio.2009.10.006 · External reference
Recent progresses of understanding the viscosity of concentrated protein solutions
10.1016/j.coche.2017.04.001 · 2017 · External reference
10.1016/j.bpj.2014.02.036
10.1016/j.bpj.2014.02.036 · External reference
10.1016/j.jcis.2020.06.105
10.1016/j.jcis.2020.06.105 · External reference
Computational tool for the early screening of monoclonal antibodies for their viscosities
10.1080/19420862.2015.1099773 · 2016 · External reference
Technology development to evaluate the effectiveness of viscosity reducing excipients
10.1016/j.ijpharm.2022.122204 · 2022 · External reference
10.1016/j.csbj.2022.09.035 · Admitted local publication
10.1016/j.tibtech.2018.05.008
10.1016/j.tibtech.2018.05.008 · External reference
10.1038/nrd1033
10.1038/nrd1033 · External reference
10.1038/nbt.1588
10.1038/nbt.1588 · External reference
10.1016/j.cocis.2017.06.004
10.1016/j.cocis.2017.06.004 · External reference
10.1038/nbt.2825
10.1038/nbt.2825 · External reference
10.1146/annurev-immunol-082119-124838
10.1146/annurev-immunol-082119-124838 · External reference
10.1016/j.csbj.2020.12.024
10.1016/j.csbj.2020.12.024 · External reference
10.1016/j.sbi.2016.06.003
10.1016/j.sbi.2016.06.003 · External reference
Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeutics
10.1016/j.addr.2009.07.014 · 2009 · External reference
Antibody specific epitope prediction—emergence of a new paradigm
10.1016/j.coviro.2015.03.012 · 2015 · External reference
Directed evolution of chemotaxis inhibitory protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodies
10.1093/protein/gzp062 · 2010 · External reference
Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes
10.1073/pnas.1209292109 · 2012 · External reference
10.1371/journal.pone.0116577
10.1371/journal.pone.0116577 · External reference
Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics
10.1080/19420862.2021.2020082 · 2022 · External reference
10.1038/nature14539
10.1038/nature14539 · External reference
10.1016/j.drudis.2020.11.037
10.1016/j.drudis.2020.11.037 · External reference
Data science tools and applications on the way to Pharma 4.0
10.1016/j.drudis.2019.06.005 · 2019 · External reference
10.1016/j.drudis.2020.12.009
10.1016/j.drudis.2020.12.009 · External reference
10.1021/acs.chemrev.6b00163
10.1021/acs.chemrev.6b00163 · External reference
Integration of experimental data and use of automated fitting methods in developing protein force fields
10.1038/s42004-022-00653-z · 2022 · External reference
Machine-learning-based dynamic-importance sampling for adaptive multiscale simulations
10.1038/s42256-021-00327-w · 2021 · External reference
Multiscale simulations of complex systems by learning their effective dynamics
10.1038/s42256-022-00464-w · 2022 · External reference
Advances in molecular dynamics simulations and enhanced sampling methods for the study of protein systems
2020 · External reference
Biomolecular modeling thrives in the age of technology, Nature Computational
2021 · External reference
10.1146/annurev-physchem-042018-052331
10.1146/annurev-physchem-042018-052331 · External reference
Neural relational inference to learn long-range allosteric interactions in proteins from molecular dynamics simulations
10.1038/s41467-022-29331-3 · 2022 · External reference
10.1038/s41596-021-00659-2
10.1038/s41596-021-00659-2 · External reference
10.1016/j.imed.2021.10.001
10.1016/j.imed.2021.10.001 · External reference
